Transcranial Direct Current Stimulation and Treadmill in Cerebral Palsy
The Therapeutic Effect of Transcranial Direct Current Stimulation and Treadmill in Children With Cerebral Palsy
2 other identifiers
interventional
5
1 country
1
Brief Summary
Background: Cerebral Palsy (CP) is characterized by altered excitability in bilateral sensorimotor cortical areas. Previous research using unilateral anodal transcranial direct current stimulation (tDCS) has yielded inconsistent results, highlighting a need for alternative stimulation approaches. Objective: This study evaluated the feasibility, safety, and preliminary efficacy of combining bilateral anodal transcranial direct current stimulation (tDCS) over the sensorimotor cortices with treadmill training in children with CP. Methods: A within-subjects case series was conducted with five children with CP. Participants received ten sessions of treadmill training (at 50% of their maximum over-ground speed) concurrently with bilateral anodal tDCS. Outcomes, assessed pre- and post-intervention, included postural alignment (medio-lateral and anterior-posterior), ankle dorsiflexion range of motion, gait variability, walking tolerance (6-minute walk test), motor function (GMFM-66), and hip/knee range of motion. Statistical analysis was performed using paired t-tests and effect sizes (Hedges' g). Anticipated Impact: This study will pioneer a novel bilateral tDCS montage for CP rehabilitation. The findings are expected to provide critical insights into the synergistic relationship between neuromodulation and physical training, ultimately informing more effective, evidence-based interventions to enhance motor function and participation in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 15, 2026
CompletedJanuary 15, 2026
January 1, 2026
4.8 years
November 22, 2025
January 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Gait speed
Gait speed (meters/second)
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Gait variability
Gait variability (dimensionless autocorrelation coefficient)
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Walking endurance
Walking endurance assessed using the 6-Minute Walk Test (distance in meters walked within 6 minutes intervals)
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Developmental Motor function
Gross motor function measure - Item set scale (Total Score, Higher score good motor function development, lower score poor motor function development)
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Postural Alignment
Postural alignment (medio-lateral displacement in cm) Postural alignment (anterior-posterior displacement in cm)
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Secondary Outcomes (2)
Spasticity
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Joint Range of Motion
Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)
Study Arms (1)
tDCS & Treadmill
EXPERIMENTALThe therapeutic protocol commenced with two treadmill familiarization sessions. This was followed by ten combined treatment sessions.
Interventions
The therapeutic protocol commenced with two treadmill familiarization sessions. This was followed by ten combined treatment sessions, each consisting of a 12-minute interval: a 1-minute warm-up, a 10-minute simultaneous treadmill training and tDCS therapy period, and a 1-minute cool-down. Treadmill speed was initiated at 50% of the child's maximum ground speed from the 6-Minute Walk Test (6MWT) and was progressively increased based on individual tolerance.
Eligibility Criteria
You may qualify if:
- Gross Motor Function Classification System (GMFCS) level of I-III
- ability to walk independently for at least 10 meters
- IQ greater than 70
You may not qualify if:
- history of orthopedic surgery
- history of neurolytic blocks,
- history of Botox injections in the past six months
- Presence of concurrent orthopedic impairments
- Presence of epilepsy
- Presence of intracranial metal implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sharjahlead
- Jordan University of Science and Technologycollaborator
Study Sites (1)
University of Sharjah
Sharjah city, Emirate of Sharjah, 27272, United Arab Emirates
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hikmat Hadoush
University of Sharjah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. / Associate professor
Study Record Dates
First Submitted
November 22, 2025
First Posted
January 15, 2026
Study Start
July 1, 2020
Primary Completion
May 1, 2025
Study Completion
July 1, 2025
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 6 months after publication of the primary study results and available for 5 years thereafter.
- Access Criteria
- De-identified IPD will be available upon reasonable request from qualified researchers for the purpose of academic, educational, or non-commercial research.
De-identified individual participant data (IPD) collected during the study will be made available. This will include analyzable datasets underlying the reported outcomes, such as gait parameters, range of motion measures, walking endurance (6-Minute Walk Test), and Gross Motor Function Measure (GMFM-66) scores. No direct identifiers will be shared. Supporting documentation, including the study protocol and statistical analysis plan, may also be made available upon request.